Aug 10, 2026 08:30AM
Jun 29, 2026 06:01AM
Jun 29, 2026 06:00AM
Jun 29, 2026 06:00AM
Jun 29, 2026 06:00AM
May 7, 2026 08:30AM
Mar 19, 2026 08:30AM Theravance Biopharma, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
Mar 3, 2026 08:31AM
Mar 3, 2026 08:30AM
Nov 20, 2025 11:00AM
Nov 20, 2025 11:00AM
Nov 19, 2025 06:00AM
Nov 10, 2025 04:05PM
Oct 29, 2025 06:00AM Theravance Biopharma to Present Data on Ampreloxetine at the 36th International Symposium on The Autonomic Nervous System
Oct 27, 2025 06:00AM
Oct 14, 2025 06:02AM
Oct 14, 2025 06:00AM
Oct 1, 2025 01:20PM
Oct 1, 2025 01:13PM
Sep 2, 2025 06:00AM
Aug 26, 2025 05:21AM BTIG Reiterates Buy Rating on Theravance Biopharma (TBPH)
Aug 25, 2025 06:00AM
Aug 25, 2025 06:00AM
Aug 12, 2025 04:05PM
Jul 28, 2025 06:00AM
Jul 23, 2025 06:00AM
Jun 26, 2025 06:00AM
Jun 26, 2025 06:00AM Theravance Biopharma Announces Approval of YUPELRI® (revefenacin) by China's NMPA
Jun 2, 2025 06:20AM
Jun 2, 2025 06:00AM
May 13, 2025 06:00AM
May 9, 2025 12:00PM
May 8, 2025 04:05PM
Apr 28, 2025 06:00AM
Apr 24, 2025 06:00AM Theravance Biopharma to Report First Quarter 2025 Financial Results on May 8, 2025
Apr 7, 2025 03:55PM
Mar 31, 2025 06:00AM
Mar 27, 2025 06:00AM
Feb 26, 2025 04:05PM
Feb 20, 2025 06:00AM
Feb 12, 2025 06:00AM
Feb 5, 2025 06:00AM Theravance Biopharma to Participate in an Upcoming Investor Conference
Dec 17, 2024 06:00AM
Nov 20, 2024 06:00AM
Nov 12, 2024 04:05PM
Oct 24, 2024 06:00AM
Oct 18, 2024 09:02AM
Oct 18, 2024 09:00AM
Aug 27, 2024 06:00AM Theravance Biopharma to Participate in an Upcoming Investor Conference
Aug 5, 2024 04:05PM

328,342 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All